Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Descor LLC
WARNING LETTER
•Descor LLC•August 19, 2014

Descor LLC – FDA Warning Letter, Aug 19, 2014

Record Details

On August 19, 2014, the FDA issued a Warning Letter to Descor, LLC, regarding their product "Asset Bee Pollen," distributed via www.assetcapsules4u.com. An FDA laboratory analysis confirmed the product contained undeclared sibutramine, an active pharmaceutical ingredient previously withdrawn from the U.S. market due to increased risks of heart attack and stroke. Previous Descor products ("Asset Extreme," "Asset Extreme Plus," "Asset Bold") also contained sibutramine.

The FDA determined "Asset Bee Pollen" is an unapproved new drug and a misbranded drug. Sibutramine is excluded from the definition of a dietary supplement because it was authorized for investigation as a new drug before being marketed as a dietary supplement or food. The product is considered a drug due to its intended use for weight loss, increased energy, and metabolism speed. It is an unapproved new drug under sections 505(a) and 301(d) of the FD&C Act because it is not generally recognized as safe and effective and lacks an FDA-approved application.

Furthermore, "Asset Bee Pollen" is misbranded under section 502 of the FD&C Act because it lacks adequate directions for use, which are impossible to provide given sibutramine's prescription-only status (prior to withdrawal) and serious safety risks. The labeling is also false and misleading under section 50

Company
Descor LLC
Inspection date
August 19, 2014
Product type
Drugs
Office
Baltimore District Office
Person
  • Randy F. Pack (Program Division Director)
View Company Profile

ID · cb4bf8ba-263f-4a60-943d-d2d429d9a8da

Violation Codes10
21 U.S.C. 331(a)21.U.S.C. 355(a)21 U.S.C. 331(d)21 U.S.C. 35221 U.S.C. 321(ff)(3)(B)(ii)21 U.S.C. 321(g)(1)21 U.S.C. 321(p)21 U.S.C. 351(a)(2)(A)21 U.S.C. 321(n)21 U.S.C. 352(f)(1)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Descor LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.